Evidence map›Paper›PMID 41713190›Full record

ReviewCurrent opinion in genetics & development2026

Facilitators may represent a new class of regulatory elements.

Mira Kassouf, Alexandra Rampasekova, Doug Higgs

Abstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mira KassoufLaboratory of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Electronic address: mira.kassouf@imm.ox.ac.uk.
Alexandra RampasekovaLaboratory of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Doug HiggsLaboratory of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK. Electronic address: doug.higgs@imm.ox.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene expression is controlled by three main cis-regulatory elements: enhancers, promoters, and insulators. When active and bound by transcription factors, co-factors, and architectural proteins, these elements together shape the genome's structure and function. Although each class has distinct features, the functions of these classes often overlap. Chromatin analyses suggest that the mammalian genome contains over a million cis-regulatory elements. Many are classified as enhancers based on chromatin signatures, and yet they may not act as classical enhancers in traditional assays. However, these enhancer-like elements can augment enhancer activity in their native chromosomal context. We refer to these as 'facilitators.' The mechanisms by which facilitators regulate gene expression remain unclear, though two possibilities are proposed. First, facilitators may supply essential factors or raise their concentration to form transcriptional hubs that enhance gene expression. Second, they might help organise chromatin architecture, bringing enhancers and promoters into proximity to increase their interaction. We discuss current evidence suggesting that this subset of uncharacterised cis-acting sequences may constitute a distinct class of regulatory elements that facilitate classical enhancer activity.

Indexed as

Enhancer Elements, GeneticGene Expression RegulationRegulatory Sequences, Nucleic AcidAnimalsChromatinGenomeHumansInsulator ElementsPromoter Regions, GeneticTranscription FactorsChromatinTranscription Factors

Identifiers

PMID41713190
PMCPMC13328058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.